by Annie De Groot | Oct 21, 2013 | Thinking Out Loud -Blog
https://www.newscientist.com/article/mg21829164.200-us-invokes-emergency-act-to-keep-h7n9-flu-at-bay.html#.UmUyniRQ25c But there is another problem: H7 flu is poor at stimulating immunity. Virologists at the European Flu Summit in Brussels last week told New Scientist...
by Annie De Groot | Oct 17, 2013 | Thinking Out Loud -Blog
WHO: Human infection with avian influenza A(H7N9) virus – update Disease outbreak news 16 OCTOBER 2013 – The National Health and Family Planning Commission, China notified WHO of a new laboratory-confirmed case of human infection with avian influenza A(H7N9)...
by Annie De Groot | Jul 19, 2013 | Thinking Out Loud -Blog
EpiVax World Tour: August – October 2013 EpiVax is continuing their ‘world tour’! Where in the world is Dr. Annie De Groot going to be next? Over the next few months, she will be visiting Paris, Berlin, Basel, Amsterdam, Osaka, Tokyo and Barcelona....
by Annie De Groot | May 15, 2013 | Events
EpiVax was in Japan from May 8th – 15th hosting our semiannual immunogenicity seminar. The ‘Westin Immunogenicity Seminar’ was a great success. Thank you to all the wonderful speakers and attendees that made our seminar possible. We are looking...
by Annie De Groot | May 11, 2013 | Thinking Out Loud -Blog
Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design Volume 9, Issue 5 May 2013 Keywords: Emerging Infectious Diseases, H7N9, Immunoinformatics, Influenza, T Cell Epitope, Vaccine, Vaccine Design Authors: Anne S. De...